US Broker Ratings

AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth with a 6.15% Upside Potential

AbbVie Inc. (NYSE: ABBV) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $351.09 billion, AbbVie is a significant..

Amgen Inc. (AMGN) Stock Analysis: Exploring a 11.52% Potential Upside in the Healthcare Sector

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to capture investor attention with its robust product portfolio and compelling market positioning. With a market capitalization of $151.21..

Visa Inc. (V) Stock Analysis: Navigating a Strong Growth Trajectory with a 7.67% Upside Potential

Visa Inc. (NYSE: V), a global leader in the financial services sector, continues to capture investor attention with its robust growth metrics and strong market presence. As a trailblazer in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech’s Promising 33.91% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector, with its market capitalization soaring to $20.72 billion. This Miami-based biopharmaceutical company has captured investor interest due to..

Coca-Cola Company (KO) Stock Analysis: Exploring an 8.13% Upside and Robust Dividend Yield

Coca-Cola Company (NYSE: KO), a titan in the consumer defensive sector, stands as a formidable player in the non-alcoholic beverage industry. With a market capitalization soaring to $308.4 billion, this..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 34.62% Potential Upside Amid Strong Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO), a heavyweight in the healthcare sector, stands as a formidable player in the diagnostics and research industry. With a robust market capitalization of $159.89..

Apple Inc. (AAPL) Stock Analysis: Unpacking a $3 Trillion Market Cap with a 13% Upside Potential

Apple Inc. (NASDAQ: AAPL), a titan in the technology sector, continues to capture the attention of investors with its formidable market cap of $3.07 trillion. As a leader in consumer..

Home Depot, Inc. (HD) Stock Analysis: Unlocking Potential with a 17% Upside

Home Depot, Inc. (NYSE: HD) stands as a stalwart in the home improvement retail sector, boasting a robust market capitalization of $362.31 billion. With its headquarters in Atlanta, Georgia, Home..

Elevation Oncology, Inc. (ELEV) Investor Outlook: Unlocking a Potential 202% Upside in the Biotech Sector

Elevation Oncology, Inc. (NASDAQ: ELEV) is a burgeoning player in the biotechnology sector, with its focus on developing innovative cancer therapies. Despite its relatively modest market capitalization of $20.73 million,..

NVIDIA Corporation (NVDA) Stock Analysis: Exploring a 42% Upside Potential for Investors

NVIDIA Corporation (NASDAQ: NVDA), a titan in the semiconductor industry, continues to capture investor attention with its impressive market performance and robust product offerings. With a staggering market capitalization of..

Automatic Data Processing, Inc. (ADP) Stock Analysis: Evaluating Its 1.81% Potential Upside Amid Robust Dividend Yield

Automatic Data Processing, Inc. (NASDAQ: ADP) remains a stalwart in the technology sector, specifically within the software application industry, renowned for its comprehensive human capital management (HCM) solutions. With a..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 20.85% Potential Upside Amidst Dividend Strength

Pfizer, Inc. (NYSE: PFE), a global leader in the healthcare sector, continues to capture investor attention with its robust portfolio of biopharmaceutical products. Known for its pioneering efforts in drug..

Costco Wholesale Corporation (COST) Stock Analysis: Evaluating Growth Potential with a 4.34% Upside

As one of the stalwarts in the Consumer Defensive sector, Costco Wholesale Corporation (NASDAQ: COST) continues to impress with its robust business model and expansive global presence. With a market..

GlycoMimetics, Inc. (GLYC) Stock Analysis: A Biotech Underdog with Speculative Potential

GlycoMimetics, Inc. (GLYC), a biotech firm specializing in developing therapies for cancers and inflammatory diseases, presents a fascinating case for investors looking to explore high-risk, high-reward opportunities in the healthcare..

TELA Bio, Inc. (TELA): Investor Outlook Reveals Potential 468% Upside Amidst Healthcare Innovation

TELA Bio, Inc. (NASDAQ: TELA), a healthcare company specializing in medical devices, is capturing investor attention with its potential for substantial upside. With a market capitalization of $40.35 million and..

Super Micro Computer, Inc. (SMCI) Stock Analysis: Unveiling a 44.64% Potential Upside

Super Micro Computer, Inc. (NASDAQ: SMCI) is making waves in the technology sector, particularly within the computer hardware industry. Known for its high-performance server and storage solutions, the company is..

Acuren Corporation (TIC) Stock Analysis: Investor Outlook on a 42% Potential Upside

Acuren Corporation (TIC), a key player in the Industrials sector, is poised for intriguing developments that investors might find appealing, particularly with the stock’s projected potential upside of 42.42%. The..

Endeavour Silver Corporation (EXK) Stock Analysis: A 77% Upside Potential in the Silver Sector

Endeavour Silver Corporation (NYSE: EXK), a distinguished name in the silver mining industry, could be a compelling investment opportunity for those seeking exposure in the Basic Materials sector. Headquartered in..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 26% Potential Upside with Robust Dividend Yield

Merck & Company, Inc. (NYSE: MRK) remains a stalwart in the healthcare sector, with its vast global footprint and diverse pharmaceutical and animal health offerings. With a market capitalization of..

Nike, Inc. (NKE) Investor Outlook: Evaluating a 26.92% Potential Upside in the Consumer Cyclical Sector

Nike, Inc. (NYSE: NKE), a titan in the Consumer Cyclical sector and a globally recognized leader in the Footwear & Accessories industry, continues to captivate investors’ attention with its robust..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds